|
End-of-day quote
Taipei Exchange
2026-10-05
|
5-day change | 1st Jan Change | ||
| 15.85 TWD | -0.94% |
|
-4.52% | -23.06% |
| 08-12 | Enimmune Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-08 | Enimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 36.23M | - | - | - | - | - |
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
- Stock Market
- Stocks
- 6564 Stock
- Charts Enimmune corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
